Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ120512060,25
KB100710090,10
PKN82,6982,711,39
Msft479,2479,33-0,20
Nokia4,4584,4751,29
IBM280,33281-0,79
Mercedes-Benz Group AG48,8148,820,73
PFE23,9223,930,21
20.06.2025 13:14:58
Indexy online
AD Index online
select
AD Index online
 

Aphria
Poslední obchod Změna (%) Změna Objem obchodů ()
- - -
Poslední obchod Změna (%) Změna Objem obchodů ()
- - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiAphria Inc
TickerAPHA
Kmenové akcie:Ordinary Shares
RICAPHA.TO
ISIN-
Poslední známé roční výsledky31.05.2020
Poslední známé čtvrtletní výsledky28.02.2021
Počet zaměstnanců k 31.05.2020 1 200
Akcie v oběhu k 28.02.2021 316 795 419
MěnaCAD
Kontaktní informace
Ulice1 Adelaide Street East, Suite 2310
MěstoTORONTO
PSČM5C 2E9
ZeměCanada
Kontatní osoba 
Funkce kontaktní osoby 
Fax15193222916

Business Summary: Aphria Inc is a Canada-based cannabis company. The Company's Canadian cannabis operations are comprised of its Aphria One greenhouse facility (Aphria One), facilities held through its wholly owned British Columbia-based subsidiary, Broken Coast Cannabis Ltd. (Broken Coast) and its Leamington-based subsidiary, 1974568 Ontario Limited (Aphria Diamond). Aphria One is the Company's greenhouse facility, which is located in Leamington, Ontario. Broken Coast's indoor cannabis production facility on Vancouver Island provides B.C. Bud, a cannabis brands in Canada. Its subsidiary, Avanti Rx Analytics Inc., provides testing services to its Canadian cannabis operations and allows to process, package, label and test cannabis oil as well as package, label and test dried cannabis for medicinal use. It also manufactures and distributes bottled, canned and draft craft beers. The Company has operations in Canada, Germany, Italy, Malta, Colombia and Argentina.
Financial Summary: BRIEF: For the nine months ended 28 February 2021, AphriaInc revenues increased 18% to C$459.9M. Net loss totaledC$486.7M vs. income of C$14.2M. Revenues reflect Businessesunder developement segment increase from C$490K to C$15.5M,Northern America (Region) segment increase of 12% toC$134.7M. Net loss reflects Share-based compensationincrease from C$17.6M to C$54.1M (expense), Transactioncosts increase from C$3.9M to C$37.6M (expense).
Odvětvová klasifikace
TRBC2012Alternative Medicine
RBSS2004Investment Trusts
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Pharmaceutical Preparation Manufacturing
SICPharmaceutical Preparations



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerIrwin Simon6201.03.201927.12.2018
Lead Independent Vice Chairman of the BoardRenah Persofsky6214.11.201914.11.2019
Chief Financial OfficerCarl Merton-
Chief Operating OfficerJames Meiers-14.05.201914.05.2019
Senior Vice President of Sales and MarketingBernard Yeung-14.11.201914.11.2019
Chief Strategy OfficerDenise Faltischek-14.11.201914.11.2019
Chief Legal OfficerChristelle Gedeon-01.06.201801.06.2018
Managing Director of Aphria GermanyHendrik Knopp-
Chief Corporate Affairs OfficerTamara Macgregor-14.11.2019